Jane Street Group, LLC Verastem, Inc. Transaction History

Jane Street Group, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.33 - $10.44 $44,697 - $1.41 Million	135,446 New	135,446 $54,000
Q2 2022 Aug 16, 2022	SELL	$1.02 - $1.83 $47,297 - $84,857	-46,370 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.06 - $2.1 $97,436 - $193,034	-91,921 Reduced 66.47%	46,370 $65,000
Q4 2021 Feb 15, 2022	BUY	$2.05 - $3.2 $187,197 - $292,211	91,316 Added 194.39%	138,291 $283,000
Q3 2021 Nov 16, 2021	BUY	$2.54 - $4.07 $33,726 - $54,041	13,278 Added 39.4%	46,975 $145,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $46,966 - $88,633	18,275 Added 118.5%	33,697 $138,000
Q1 2021 May 18, 2021	SELL	$1.9 - $2.82 $17,307 - $25,687	-9,109 Reduced 37.13%	15,422 $38,000
Q4 2020 Feb 17, 2021	BUY	$1.15 - $2.4 $28,210 - $58,874	24,531 New	24,531 $52,000
Q3 2020 Nov 17, 2020	SELL	$1.11 - $1.68 $936,778 - $1.42 Million	-843,945 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.69 - $4.2 $1.37 Million - $3.42 Million	813,159 Added 2641.33%	843,945 $1.45 Million
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $38,790 - $104,056	30,786 New	30,786 $82,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $229,102 - $301,052	-189,341 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$1.25 - $3.14 $236,676 - $594,530	189,341 New	189,341 $286,000
Q4 2018 Feb 15, 2019	SELL	$3.23 - $7.01 $239,010 - $518,718	-73,997 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $507,619 - $737,750	73,997 New	73,997 $536,000
Q1 2018 May 15, 2018	SELL	$2.92 - $3.81 $35,282 - $46,036	-12,083 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$2.99 - $4.85 $36,128 - $58,602	12,083	12,083 $37,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.